ARTICLE | Clinical News
Sofosbuvir/velpatasvir/voxilaprevir: Phase III data
October 31, 2016 7:00 AM UTC
Top-line data from the double-blind, international Phase III POLARIS-1 trial in 415 patients with chronic HCV genotypes 1-6 infection who failed prior treatment with an HCV NS5A protein inhibitor show...